Pulse of The Hill

Loading navigation…

LOBBYIST

Kimberlee Trzeciak

Registrant in 2026 disclosures: Capitol Hill Consulting Group

Based on 14 cached source filings; newest posted Oct 20, 2026. Disclosure history is not real-time employment verification.

← Back to lobbyists

Following Kimberlee Trzeciak’s registrations? Leave your email and we’ll follow up personally when their filings change.

29ACTIVITIES
11DISCLOSED CLIENTS
5BILLS

Revolving door — covered positions

Prior government positions reported in lobbying disclosures. These are historical roles, not a statement of current employment.

FDA. Dep. Commissioner

+ 2 more disclosed positions in the full intelligence view

Disclosed clients

11

Clients named in filings listing Kimberlee, across all filing years. Activity counts are disclosure mentions, not a list of current engagements.

Charles River Laboratories International, Inc3 activities

+ 9 more disclosed clients — available with full intelligence access

Limited preview · paid research

See the research behind a profile.

Connect disclosed clients, bills and source filings. The full federal calendar and records stay paid.

Separate example—not a dossier about this person, an endorsement or proof of participation.

Federal Intelligence: $2,500 one-time for three months or $9,000 for twelve months prepaid. One named user; no automatic renewal.

Secure setup within one business day after verified payment. Your term starts at activation.

Only need a finished deliverable? Commission a focused federal research brief · $1,000 one-time →. Scope agreed before payment; no account access included.

Account options and coverage

Unlock the full client and employer history, complete bill and issue activity, professional contact sources where available, and the joined map of where this lobbyist appears across the Pulse database. Missing contacts are not presented as verified.

A free alert subscription does not grant full access.

Bill references in disclosures

5

An explicitly named Congress takes precedence; otherwise the Congress is estimated from the filing year. Consult the original filing before relying on a historical reference.

+ 3 more bills referenced in their activities — available with full intelligence access

Topics in Filings

16

Policy topics Kimberlee files on across all their LD-2 activities.

Surrounding improvements to clinical research capabilities and modernization×3

+ 15 more topics in the full dossier

Pulled from the org’s own LD-2 disclosures. See the source filings ↓

Source filing samples

Most recent available disclosure for each client shown above. Consult the original filing to verify context; these samples are not the complete filing history.

Association for Accessible Medicines (Formerly Generic Pharmaceutical Assoc.) · 2025 fourth_quarter filing ↗

Charles River Laboratories International, Inc · 2026 first_quarter filing ↗

Issue mix

LDA general-issue codes weighted by activity count.

Medicare/Medicaid12
Health Issues8
Trade (domestic/foreign)4

+ 4 more issue areas in the full intelligence view

Is this you? Claim or correct this profile.